Q32 Bio Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Q32 Bio stock has a consensus rating of "Strong Buy" and an average price target of $14.25. The average 1-year stock price forecast is 12.74% higher than the current stock price, while the lowest is $10 (-20.89%) and the highest is $20 (+58.23%).

Price Target: $14.25 (+12.74%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$14.25	$13.5	$20
Change	-20.89%	+12.74%	+6.80%	+58.23%

Analyst Ratings

The average analyst rating for Q32 Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	2	2	2	4
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	3	3	3	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Poland Wells Fargo	Wells Fargo	Hold Maintains $10	Hold	Maintains	$10	-20.89%	May 28, 2026
Joseph Catanzaro Mizuho Securities	Mizuho Securities	Buy Initiates $14	Buy	Initiates	$14	+10.76%	May 22, 2026
Imogen Mansfield Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates n/a	Buy	Initiates	n/a	n/a	May 18, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $13	Buy	Reiterates	$13	+2.85%	May 5, 2026
Jay Olson Oppenheimer	Oppenheimer	Buy Maintains $20	Buy	Maintains	$20	+58.23%	Mar 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.00M

from 53.74M

-98.14%

from 53.74M

Revenue Next Year

1.00M

from 1.00M

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	6.65M	-6.65M	-	53.74M	1.00M
Revenue Growth	-	-	-	-	-	-98.14%
Operating Income	-36.69M	-39.23M	-48.26M	-66.10M	16.90M	-36.23M
Net Income	-37.56M	-42.81M	-53.74M	-47.73M	29.82M	-33.74M
Free Cash Flow	-	-8.73M	-41.84M	-37.95M	4.52M	-33.50M
No. Analysts	-	-	-	-	-	5

Revenue Forecast

Revenue	2026	2027	2028
High	5.0M
Avg	1,000,000
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-90.7%
Avg	-98.1%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-